NovoCure Ltd — Director's Dealing 2015

Oct 1, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-01

Reporting Person: LEUNG GABRIEL (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Buy Ordinary Shares	$3.44	2021-09-15	Ordinary Shares (314743)		Direct
Options to Buy Ordinary Shares	$7.03	2023-02-20	Ordinary Shares (88695)		Direct
Options to Buy Ordinary Shares	$7.48	2024-02-26	Ordinary Shares (29565)		Direct

Footnotes

F1: Options to buy 264,384 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 50,359 ordinary shares will vest on September 15, 2016, subject to Mr. Leung's continued service through such date.

F2: Options to buy 44,347 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 44,348 ordinary shares will vest and become exercisable in equal installments on February 20, 2016 and 2017, subject to Mr. Leung's continued service through such dates.

F3: Options to buy 7,391 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 22,174 ordinary shares will vest and become exercisable in equal installments on February 26, 2016, 2017 and 2018, subject to Mr. Leung's continued service through such dates.